*Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
†Yale University School of Medicine, New Haven, CT
Supported, at least in part, by the NIH grant T32 DK007533-35.
W.W.C.: Ironwood—scientific advisory board. C.C.T.: Apollo Endosurgery—consultant/research support (consulting fees/institutional research grants), Aspire Bariatrics—research support (institutional research grant), BlueFlame Healthcare Venture Fund—General Partner, Boston Scientific—consultant (consulting fees), Covidien/Medtronic—consultant (consulting fees), EnVision Endoscopy (board member), Fractyl—consultant/advisory board member (consulting fees), GI Dynamics—consultant (consulting fees)/research support (institutional research grant), GI Windows—ownership interest, Olympus/Spiration—consultant (consulting fees)/research support (equipment loans), Spatz—research support (institutional research grant), USGI Medical—Consultant (consulting fees)/advisory board member (consulting fees)/research support (research grant). The remaining authors declare that they have nothing to disclose.
Address correspondence to: Christopher C. Thompson, MD, MSc, Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women’s Hospital, 75 Francis Street, Boston, MA 02115 (e-mail: [email protected]).
